These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12852760)

  • 1. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.
    Huang HS; Chiou JF; Fong Y; Hou CC; Lu YC; Wang JY; Shih JW; Pan YR; Lin JJ
    J Med Chem; 2003 Jul; 46(15):3300-7. PubMed ID: 12852760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
    Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
    Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.
    Perry PJ; Gowan SM; Reszka AP; Polucci P; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Aug; 41(17):3253-60. PubMed ID: 9703471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones.
    Huang HS; Chou CL; Guo CL; Yuan CL; Lu YC; Shieh FY; Lin JJ
    Bioorg Med Chem; 2005 Mar; 13(5):1435-44. PubMed ID: 15698759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives.
    Lee CC; Huang KF; Lin PY; Huang FC; Chen CL; Chen TC; Guh JH; Lin JJ; Huang HS
    Eur J Med Chem; 2012 Jan; 47(1):323-36. PubMed ID: 22100139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase.
    Perry PJ; Read MA; Davies RT; Gowan SM; Reszka AP; Wood AA; Kelland LR; Neidle S
    J Med Chem; 1999 Jul; 42(14):2679-84. PubMed ID: 10411488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of telomerase inhibitory, hTERT repressing, and anti-proliferation activities of symmetrical 1,8-disubstituted amidoanthraquinones.
    Lee CC; Huang KF; Chang DM; Hsu JJ; Huang FC; Shih KN; Chen CL; Chen TC; Chen RH; Lin JJ; Huang HS
    Eur J Med Chem; 2012 Apr; 50():102-12. PubMed ID: 22357112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSC746364, NSC746365, and NSC746366: the spectra of cytotoxicity and molecular correlates of response to telomerase activity.
    Huang HS; Huang KF; Lee CC; Chen CL; Li CL; Lin JJ
    Anticancer Drugs; 2010 Feb; 21(2):169-80. PubMed ID: 19884821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing cell-based reporter systems for the analysis of hTERT expression.
    Huang YY; Shih JW; Lin JJ
    Methods Mol Biol; 2007; 405():87-96. PubMed ID: 18369819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives.
    Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL
    Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
    Kong BH; Song Y; Ma DX; Qu X; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, telomerase evaluation and anti-proliferative studies on various series of diaminoanthraquinone-linked aminoacyl residue derivatives.
    Huang FC; Huang KF; Chen RH; Wu JE; Chen TC; Chen CL; Lee CC; Chen JY; Lin JJ; Huang HS
    Arch Pharm (Weinheim); 2012 Feb; 345(2):101-11. PubMed ID: 21956661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
    Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
    Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
    Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
    Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
    Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of small molecule inhibitors of telomerase activity through transcriptional regulation of hTERT and calcium induction pathway in human lung adenocarcinoma A549 cells.
    Rao YK; Kao TY; Wu MF; Ko JL; Tzeng YM
    Bioorg Med Chem; 2010 Oct; 18(19):6987-94. PubMed ID: 20813535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro.
    Hayakawa N; Nozawa K; Ogawa A; Kato N; Yoshida K; Akamatsu Ki; Tsuchiya M; Nagasaka A; Yoshida S
    Biochemistry; 1999 Aug; 38(35):11501-7. PubMed ID: 10471302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of telomerase by human cytomegalovirus.
    Strååt K; Liu C; Rahbar A; Zhu Q; Liu L; Wolmer-Solberg N; Lou F; Liu Z; Shen J; Jia J; Kyo S; Björkholm M; Sjöberg J; Söderberg-Nauclér C; Xu D
    J Natl Cancer Inst; 2009 Apr; 101(7):488-97. PubMed ID: 19318640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.